Patents by Inventor Dariusz Mateusz Suchy

Dariusz Mateusz Suchy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220118088
    Abstract: The present invention belong to the field of biotechnology, in particular to the field of galenics. The present invention is directed to an aqueous pharmaceutical composition comprising 1-50 mg/ml of a human or humanized full length IgG4, e.g. natalizumab, and a formulation selected from (i) to (iii), as further defined in the claims. The present invention is further directed to a method for producing said pharmaceutical composition, and medical uses thereof. Finally, also provided is a method for stabilizing human or humanized full length IgG4, e.g. natalizumab, as further defined in the claims.
    Type: Application
    Filed: May 19, 2021
    Publication date: April 21, 2022
    Applicant: POLPHARMA BIOLOGICS S.A.
    Inventors: Dariusz Mateusz Suchy, Malgorzata Bozena Tracka, Kornelia Bogumila Wisniewska, Michael Josef Safinowski, Klemen Spaninger, Piotr Marcin Zien
  • Publication number: 20210283252
    Abstract: The present invention belong to the field of biotechnology, in particular to the field of galenics. The present invention is directed to an aqueous pharmaceutical composition comprising 1-50 mg/ml of a human or humanized full length IgG4, e.g. natalizumab, and a formulation selected from (i) to (iii), as further defined in the claims. The present invention is further directed to a method for producing said pharmaceutical composition, and medical uses thereof. Finally, also provided is a method for stabilizing human or humanized full length IgG4, e.g. natalizumab, as further defined in the claims.
    Type: Application
    Filed: May 19, 2021
    Publication date: September 16, 2021
    Inventors: Dariusz Mateusz Suchy, Malgorzata Bozena Tracka, Kornelia Bogumila Wisniewska, Michael Josef Safinowski, Klemen Spaninger, Piotr Marcin Zien
  • Publication number: 20190374639
    Abstract: The present invention belong to the field of biotechnology, in particular to the field of galenics. The present invention is directed to an aqueous pharmaceutical composition comprising 1-50 mg/ml of a human or humanized full length IgG4, e.g. natalizumab, and a formulation selected from (i) to (iii), as further defined in the claims. The present invention is further directed to a method for producing said pharmaceutical composition, and medical uses thereof. Finally, also provided is a method for stabilizing human or humanized full length IgG4, e.g. natalizumab, as further defined in the claims.
    Type: Application
    Filed: November 21, 2017
    Publication date: December 12, 2019
    Inventors: Dariusz Mateusz Suchy, Malgorzata Bozena Tracka, Kornelia Bogumila Wisniewska, Michael Josef Safinowski, Klemen Spaninger, Piotr Marcin Zien